- WORK Medical Technology Group LTD announced the pricing of a registered direct offering on **September 25, 2025**, expecting to generate approximately **$2.9 million** in gross proceeds.  **[1929783_0001213900-25-093072_ea025892301ex99-1_workmed.htm:0]** 
- The offering includes the sale of **38,999,334** Class A ordinary shares or pre-funded warrants at a purchase price of **$0.075 per share**.  **[1929783_0001213900-25-093072_ea025892301ex99-1_workmed.htm:0]** 
- The transaction closed on **September 26, 2025**, with the net proceeds intended for **working capital and general corporate purposes**.  **[1929783_0001213900-25-093072_ea025892301ex99-1_workmed.htm:0]** **[1929783_0001213900-25-093072_ea0258923-6k_workmed.htm:1]** 
- Univest Securities, LLC acted as the sole placement agent, receiving a fee of **8.0%** of the aggregate gross proceeds.  **[1929783_0001213900-25-093072_ea025892301ex99-1_workmed.htm:0]** **[1929783_0001213900-25-093072_ea0258923-6k_workmed.htm:2]**

WORK Medical Technology Group LTD announces pricing of registered direct offering

- For the six months ended March 31, 2025, WORK Medical Technology Group LTD reported **revenues of $4,543,585**, a **14.4% decrease** compared to the prior year, and a **net loss of $29,425**, contrasting with net income of $234,854 for the six months ended March 31, 2024.  **[1929783_0001213900-25-080354_ea024829001ex99-2_work.htm:0]** **[1929783_0001213900-25-080354_ea024829001ex99-2_work.htm:1]** **[1929783_0001213900-25-080354_ea024829001ex99-1_work.htm:1]** **[1929783_0001213900-25-080354_ea024829001ex99-2_work.htm:2]** 
- Despite the revenue decline, the company's gross margin improved to **34.4%** for the six months ended March 31, 2025, up from 29.1% in the prior year, primarily due to an increased sales proportion of higher-margin medical devices.  **[1929783_0001213900-25-080354_ea024829001ex99-2_work.htm:0]** **[1929783_0001213900-25-080354_ea024829001ex99-2_work.htm:1]** 
- Cash and cash equivalents significantly decreased to **$1,995,767** as of March 31, 2025, from **$6,557,605** as of September 30, 2024.  **[1929783_0001213900-25-080354_ea024829001ex99-2_work.htm:0]** **[1929783_0001213900-25-080354_ea024829001ex99-1_work.htm:0]** 
- The company is undergoing a strategic adjustment, scaling down its mask business due to market saturation and expanding investment in higher-value medical devices, which constituted **92.4%** of sales for the six months ended March 31, 2025.  **[1929783_0001213900-25-080354_ea024829001ex99-2_work.htm:0]** **[1929783_0001213900-25-080354_ea024829001ex99-2_work.htm:1]**

WORK Medical Technology Group (WOK)